WLDS

#5038
Wearable Devices Ltd. - Ordinary Share
2.2 3 USD
-0.01%
Market Price
Settore: Tecnologia
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
2.23
2.23
Intervallo Annuale
0.61
11.40
Variazione giornaliera
-0.89%
Variazione Mensile
-10.44%
Variazione di 6 mesi
+185.90%
Variazione Annuale
+106.48%
Chiusura Precedente
2.2 5
Open
2.2 3
Minimo
2.2 3
Massimo
2.2 3
Volume
4
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
Wearable Devices Ltd. current report, Q3 FY2026
6-K
Current report, Q3 FY2026
Wearable Devices Ltd. current report, Q3 FY2026
6-K
Current report, Q3 FY2026
Wearable Devices Ltd. current report, Q3 FY2026
6-K
Current report, Q3 FY2026
Wearable Devices Ltd. current report, Q3 FY2026
6-K
Current report, Q3 FY2026
Wearable Devices Ltd. current report, Q3 FY2026
6-K
Current report, Q2 FY2026
Wearable Devices Ltd. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Wearable Devices Ltd. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Wearable Devices Ltd. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Wearable Devices Ltd. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Wearable Devices Ltd. current report, Q2 FY2026
6-K

Wearable Devices Ltd. current report, Q1 FY2025

Full document

Business Context and Reporting Period

Company: Wearable Devices Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: March 13, 2025
Reporting Period: Month of March 2025
Principal Executive Offices: 5 Ha-Tnufa Street, Yokne-am Illit, Israel 2066736

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate action regarding capital structure.

Material Changes

The Company announced a 1-for-4 Reverse Share Split effective March 17, 2025. Key details include:

  • Share Consolidation: Every 4 Ordinary Shares consolidate into 1 Ordinary Share.
  • Warrant Consolidation: Every 4 Warrants consolidate into 1 Warrant, with a proportionate adjustment to the exercise price.
  • Share Count Adjustment: Issued and outstanding Ordinary Shares will decrease from approximately 3,939,911 to approximately 984,978.
  • Warrant Count Adjustment: Warrants will decrease from 393,043 to 98,261.
  • Trading Symbols: Ordinary Shares ("WLDS") and Warrants ("WLDSW") will continue to trade on the Nasdaq Capital Market under existing symbols.
  • New CUSIP Numbers: Ordinary Shares (M97838201) and Warrants (M97838185).
  • Fractional Shares: No fractional shares will be issued; holdings will be rounded to the nearest whole share.

Guidance, Outlook, and Risks

The filing does not contain financial guidance, management commentary on future performance, or specific risk factors beyond the mechanics of the reverse split. The action was approved by shareholders at a Special General Meeting on February 26, 2025, and finalized by the Board of Directors.

Investor Verification Checklist

  • Verify the effective trading date of the split-adjusted shares (March 17, 2025).
  • Confirm the new CUSIP numbers for settlement purposes (M97838201 for shares, M97838185 for warrants).
  • Review the treatment of fractional shares in brokerage accounts to ensure proper rounding.
  • Check for reciprocal adjustments to the exercise price of outstanding warrants and options.

Notizie